GFVRX
Price
$14.31
Change
+$0.13 (+0.92%)
Updated
Apr 23 closing price
Net Assets
55.04M
VSTSX
Price
$252.58
Change
+$4.17 (+1.68%)
Updated
Apr 23 closing price
Net Assets
1.7T
Ad is loading...

GFVRX vs VSTSX

Header iconGFVRX vs VSTSX Comparison
Open Charts GFVRX vs VSTSXBanner chart's image
Goldman Sachs Focused Value R
Price$14.31
Change+$0.13 (+0.92%)
VolumeN/A
Net Assets55.04M
Vanguard Total Stock Mkt Idx Instl Sel
Price$252.58
Change+$4.17 (+1.68%)
VolumeN/A
Net Assets1.7T
GFVRX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFVRX vs. VSTSX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVRX is a Buy and VSTSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.7T vs. GFVRX (55M). VSTSX pays higher dividends than GFVRX: VSTSX (1.37) vs GFVRX (0.00). GFVRX was incepted earlier than VSTSX: GFVRX (10 years) vs VSTSX (9 years). GFVRX (1.93) is less costly to investors than VSTSX (0.01). GFVRX is a more actively managed with annual turnover of: 85.00 vs. VSTSX (2.00). GFVRX has a lower initial minimum investment than VSTSX: GFVRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 3.54 vs. GFVRX (-5.84). VSTSX return over 5 years is better than : 83.81 vs. GFVRX (52.82).
GFVRXVSTSXGFVRX / VSTSX
Total Expense Ratio1.260.0112,600%
Annual Report Gross Expense Ratio1.930.0119,300%
Fund Existence10 years9 years-
Gain YTD-7.802-10.51974%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets55M1.7T0%
Annual Yield % from dividends0.001.37-
Returns for 1 year-5.843.54-165%
Returns for 3 years4.1221.4119%
Returns for 5 years52.8283.8163%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEON9.870.54
+5.79%
Neonode
PMCB1.190.05
+3.93%
PharmaCyte Biotech
BANF118.782.08
+1.78%
BancFirst Corp
NWSA26.530.35
+1.34%
News Corp
CVAC3.17-0.02
-0.63%
CureVac NV